Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.52+0.09 (+6.29%)
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Zhengye Biotechnology's price to sales ratio was 4.1× on Nov 11, 2026, against 3.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.1× | +2.2 |
| 2025 | Dec 31, 2025 | 2.0× | – |
See a number that looks wrong?